Cytomegalovirus infections in renal transplant recipients. Correlation between clinical disease and results of a specific ELISA.
D000914:Antibodies, Viral / Q000032:analysis; D000961:Antilymphocyte Serum / Q000009:adverse effects / Q000627:therapeutic use; D003524:Cyclosporins / Q000009:adverse effects* / Q000627:therapeutic use; D003587:Cytomegalovirus / Q000276:immunology / Q000302:isolation & purification; D003586:Cytomegalovirus Infections / Q000209:etiology* / Q000276:immunology / Q000382:microbiology; D004797:Enzyme-Linked Immunosorbent Assay; D005334:Fever; D006084:Graft Rejection; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D016030:Kidney Transplantation; D007970:Leukopenia; D011241:Prednisone / Q000009:adverse effects* / Q000627:therapeutic use; D012306:Risk; D013601:T-Lymphocytes / Q000276:immunology; D013921:Thrombocytopenia
D000914:Antibodies, Viral; D000961:Antilymphocyte Serum; D003524:Cyclosporins; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D011241:Prednisone